ABIN401218
antibody from antibodies-online
Targeting: NFKB1
KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN401218 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (Avian) (RELA) (pSer536) antibody
- Antibody type
- Polyclonal
- Antigen
- V-Rel Reticuloendotheliosis Viral Oncogene Homolog A (Avian) (RELA)
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Antigen sequence
Synthetic peptide corresponding to
residues surrounding S536 of human
p65 (RelA)protein- Isotype
- IgG
- Vial size
- 0.1 mg
- Concentration
- 0.9 mg/mL (by UV absorbance at 280 nm)
Submitted references Measuring time-of-flight in an ultrasonic LPS system using generalized cross-correlation.
A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity.
Series introduction: the transcription factor NF-kappaB and human disease.
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
Villladangos JM, Ureña J, García JJ, Mazo M, Hernández A, Jiménez A, Ruíz D, De Marziani C
Sensors (Basel, Switzerland) 2011;11(11):10326-42
Sensors (Basel, Switzerland) 2011;11(11):10326-42
A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity.
Jeong SJ, Pise-Masison CA, Radonovich MF, Park HU, Brady JN
The Journal of biological chemistry 2005 Mar 18;280(11):10326-32
The Journal of biological chemistry 2005 Mar 18;280(11):10326-32
Series introduction: the transcription factor NF-kappaB and human disease.
Baldwin AS Jr
The Journal of clinical investigation 2001 Jan;107(1):3-6
The Journal of clinical investigation 2001 Jan;107(1):3-6
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
Baldwin AS
The Journal of clinical investigation 2001 Feb;107(3):241-6
The Journal of clinical investigation 2001 Feb;107(3):241-6
No comments: Submit comment
No validations: Submit validation data